Christopher D Hogan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: Ridgecrest Regional Hospital, 1081 N.china Lake Blvd, Ridgecrest, CA 93555 Phone: 760-446-3551 |
Joshua Ryan Radparvar, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1081 N China Lake Blvd, Ridgecrest, CA 93555 Phone: 760-446-3551 |
Charles A Shull, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Ridgecrest Regional Hospital, 1081 N.china Lake Road, Ridgecrest, CA 93555 Phone: 760-446-3551 |
Sunit Dalal, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1081 N China Lake Blvd, Ridgecrest, CA 93555 Phone: 760-446-3551 |
News Archive
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully submitted final packaging and labeling to the Food and Drug Administration (FDA) to begin selling Cobroxin, an over-the-counter (OTC) treatment for stage 2 (moderate to severe) chronic pain.
A new technique might be used to diagnose neuromuscular disorders such as multiple sclerosis or impairment from concussions by detecting and measuring subtle oscillations in a person's standing posture.
A Politico poll underscores that Ebola is causing real political danger for some Democrats. It's playing big, for instance, in North Carolina's Senate race.
At the CeBIT in Hanover, Karlsruhe Institute of Technology and the FZI Research Center for Information Technology will present innovations for our everyday life in the future.
› Verified 2 days ago